ArticleJournal of gynecologic oncology2024

Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancers.

Risako Ozawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.